These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25359403)

  • 1. Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications.
    Idris H; Lo S; Shugman IM; Saad Y; Hopkins AP; Mussap C; Leung D; Thomas L; Juergens CP; French JK
    J Am Heart Assoc; 2014 Oct; 3(6):e001086. PubMed ID: 25359403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
    Tricoci P; Newby LK; Clare RM; Leonardi S; Gibson CM; Giugliano RP; Armstrong PW; Van de Werf F; Montalescot G; Moliterno DJ; Held C; Aylward PE; Wallentin L; Harrington RA; Braunwald E; Mahaffey KW; White HD
    JACC Cardiovasc Interv; 2018 May; 11(9):856-864. PubMed ID: 29747915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.
    Koskinas KC; Ndrepepa G; Räber L; Karagiannis A; Kufner S; Zanchin T; Hieber J; Hunziker L; Mayer K; Byrne RA; Heg D; Windecker S; Kastrati A
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e006752. PubMed ID: 30545257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Zhang D; Li Y; Yin D; He Y; Chen C; Song C; Yan R; Zhu C; Xu B; Dou K
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):534-540. PubMed ID: 28191726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of troponin to diagnose periprocedural myocardial infarction: effect on composite endpoints in the British Bifurcation Coronary Study (BBC ONE).
    Cockburn J; Behan M; de Belder A; Clayton T; Stables R; Oldroyd K; Curzen N; Hildick-Smith D
    Heart; 2012 Oct; 98(19):1431-5. PubMed ID: 22851684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
    Chen SL; Zhang JJ; Ye F; Tian NL; Sheiban I; Jepson N; Paiboon C; Sansoto T; Kwan TW; Wen SY; Wang HC; Jiang TM; Wang Y; Chen LL; Qiu CG; Zhang YJ; Chen MX; De Maria A
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
    Hara H; Serruys PW; Takahashi K; Kawashima H; Ono M; Gao C; Wang R; Mohr FW; Holmes DR; Davierwala PM; Head SJ; Thuijs DJFM; Milojevic M; Kappetein AP; Garg S; Onuma Y; Mack MJ;
    J Am Coll Cardiol; 2020 Oct; 76(14):1622-1639. PubMed ID: 33004127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials.
    Spitzer E; de Vries T; Cavalcante R; Tuinman M; Rademaker-Havinga T; Alkema M; Morel MA; Soliman OI; Onuma Y; van Es GA; Tijssen JGP; McFadden E; Serruys PW
    JACC Cardiovasc Interv; 2017 Apr; 10(7):658-666. PubMed ID: 28385402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.
    Wang HY; Xu B; Dou K; Guan C; Song L; Huang Y; Zhang R; Xie L; Zhang M; Yan H; Yang W; Wu Y; Yang Y; Qiao S; Gao R; Stone GW
    JACC Cardiovasc Interv; 2021 Aug; 14(15):1623-1634. PubMed ID: 34353593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).
    Moussa ID; Klein LW; Shah B; Mehran R; Mack MJ; Brilakis ES; Reilly JP; Zoghbi G; Holper E; Stone GW;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):27-36. PubMed ID: 23894025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Kim JH; Kim BK; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):477-485. PubMed ID: 29266736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention.
    Liu Y; Wang W; Song J; Zhang K; Wang K; Shao C; Li P; Xu B; Yang M; Chen J; Zheng J; Tang YD
    Int J Cardiol; 2021 Jun; 333():60-68. PubMed ID: 33744346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Periprocedural Myocardial Infarction After Initial Revascularization With Left Main PCI in Patients With Recent Myocardial Infarction.
    Wang HY; Xu B; Dou K; Guan C; Song L; Huang Y; Zhang R; Xie L; Yang W; Wu Y; Qiao S; Yang Y; Gao R; Stone GW
    J Soc Cardiovasc Angiogr Interv; 2023; 2(3):100576. PubMed ID: 39130720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry.
    Arai T; Yuasa S; Miyata H; Kawamura A; Maekawa Y; Ishikawa S; Noma S; Inoue S; Sato Y; Kohsaka S; Fukuda K
    Heart Vessels; 2013 Nov; 28(6):714-9. PubMed ID: 23274577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Paolucci L; Mangiacapra F; Sergio S; Nusca A; Briguori C; Barbato E; Ussia GP; Grigioni F
    Eur Heart J; 2024 Sep; 45(33):3018-3027. PubMed ID: 38742545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Stetler J; Karatasakis A; Christakopoulos GE; Tarar MN; Amsavelu S; Patel K; Rangan BV; Roesle M; Resendes E; Grodin J; Abdullah S; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):1-6. PubMed ID: 27014962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.
    Ueki Y; Otsuka T; Bär S; Koskinas KC; Heg D; Häner J; Siontis GCM; Praz F; Hunziker L; Lanz J; Stortecky S; Pilgrim T; Losdat S; Windecker S; Räber L
    J Am Coll Cardiol; 2022 Feb; 79(6):513-526. PubMed ID: 35144742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.